Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 2 , Pages 331-340, April 2008

Maximal androgen blockade for advanced prostate cancer

  • Laurence Klotz, MD (Professor of Surgery)

      Affiliations

    • Corresponding Author InformationTel.: +1 416 480 4673; Fax: +1 416 480 6121.

Sunnybrook Health Sciences Centre, Division of Urology, University of Toronto, 2075 Bayview Avenue, #MG408, Toronto, Ontario M4N 3M5, Canada

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(08)00005-5

doi:10.1016/j.beem.2008.01.004

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 2 , Pages 331-340, April 2008

Article Tools